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Methods 1 Cohort-specific information, funding and acknowledgments
The National FINRISK Study (FINRISK, Finland) has been established in 1972; randomly selected representative population samples are recruited from different parts of Finland every five years. For this study, three cross-sectional population surveys (1997, 2002, and 2007) and
two study areas (cities of Helsinki/Vantaa and Turku/Loimaa region) were used (Peltonen et al. 2008 The population-based Oslo Health Study (HUBRO, Norway) was designed to identify health needs within Oslo and determine the priorities of the health sector (Søgaard et al. 2004) . Another aim was to identify social and geographical differences in health and associated risk factors.
HUBRO was carried out in the city of Oslo in 2001. All men and women born in 1924, 1925, 1940, 1941, 1955, 1960 and 1970, who The Swedish National study of Aging and Care in Kungsholmen (SNAC-K, Sweden) is an ongoing longitudinal study with the ultimate goal of contributing to the understanding of the ageing process and identifying possible preventive strategies to improve health and care in elderly adults (Lagergren et al. 2004 We included four sub-cohorts from the European Prospective Investigation into Cancer and Nutrition (EPIC) (Riboli et al. 2002) . EPIC is a large multi-center prospective cohort study, involving 23 European centers in 10 countries in Western Europe. EPIC was designed to study the relationship between diet and the risk of chronic diseases, particularly cancer.
EPIC-Umeå is a sub-cohort of EPIC in Sweden, It joined the EPIC study in 1996-1997 and consists primarily the Västerbotten Intervention Cohort (Oudin et al. 2012 (Beulens et al. 2010 ).
• The EPIC-Prospect study (the Netherlands) consists of 17,500 healthy women, living in Utrecht and surroundings were enrolled. Women were recruited from breast cancer screening participants, age 50-70 years at enrolment. Baseline information was collected between 1993-1997 on the basis of two self-administered questionnaires and a medical examination (Beulens et al. 2010 ).
• Funding and acknowledgments. The EPIC-MORGEN and EPIC-PROSPECT cohorts were supported by the Dutch Ministry of Public Health, Welfare and Sports (VWS),
Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), and Statistics
Netherlands.
The EPIC Oxford cohort (EPIC-Oxford, the United Kingdom) was recruited from the nationwide general population throughout the United Kingdom into the Oxford cohort, containing 65,429 men and women through medical general practices or by post between 1993 and 2000 (Danesh et al., 2007) .
The Heinz Nixdorf Risk Factors, Evaluation of Coronary Calcification, and Lifestyle (Recall) study (HNR, Germany) is an ongoing population-based, prospective cardiovascular cohort study that started in 2000. The main objective of the study is the assessment of the predictive power of coronary artery calcification for the incidence of hard coronary events such as myocardial infarction and sudden cardiac death in an unselected general population. HNR includes 4814 randomly selected participants aged 45 to 75 years from three large adjacent German cities (Essen, Mülheim, Bochum) of the densely populated and highly industrialized Ruhr Area (Schmermund et al. 2002; Stang et al. 2006 ≤10 µm (PM 10 ), >2.5 to ≤10 µm (PM coarse ; calculated as PM 10 minus PM 2.5 ), PM 2.5 absorbance, and nitrogen oxides (NO 2 -nitrogen dioxide and NO x -nitrogen oxide) at residence were estimated in each study region using Land Use Regression (LUR) models, based on a harmonized approach described elsewhere (Beelen et al. 2013; Eeftens et al. 2012a ).
Measurements of both PM and nitrogen oxides were conducted for a one-year period between 2008 and 2011 at sites chosen to represent the anticipated spatial variation of air pollution in the corresponding study area (Cyrys et al. 2012; Eeftens et al. 2012b Information System databases were used to develop LUR models in each ESCAPE study area (Beelen et al. 2013; Eeftens et al. 2012a ). Concentrations for each individual's residence were then predicted using the developed study-specific LUR models, and the extreme values were truncated to the minimum and maximum measured values at the monitoring sites.
Extrapolation of exposure values back in t ime
The predicted concentrations for PM 10 and NO 2 were back extrapolated to the time of the BP measurement, if corresponding measured data from routine network sites were available. The following standard procedure was employed: we divided the mean concentration of the respective pollutant (PM 10 or NO 2 ) at the baseline period (2-year mean: 12 months before and 12 
Exposure increments in the analyses
All exposure increments were a priori chosen centrally for the complete ESCAPE study to ensure that all papers in ESCAPE would report results on the same scale. The standardized increments were based on the mean 5 th -95 th percentile difference across all ESCAPE study areas. Results were calculated for fixed increments of exposures: 5 µg/m³ for PM 2.5 and PM coarse , 10 µg/m³ for PM 10 and NO 2 , 20 µg/m³ for NO , and 10 -5 m -1 x for PM 2.5 absorbance. Traffic load on major road fragments in a 100 m buffer was included in the analyses as a continuous variable with an increment of 4,000,000 vehicles × m/day, as well as in categories: ≤500,000 (reference); >500,000 & ≤1,500,000; >1,500,000 & ≤3,000,000; >3,000,000 vehicles × m/day. Traffic intensity at the nearest road was analyzed as a continuous variable with an increment of 5,000 vehicles/day.
Noise assessment
Since 2002 member states of the European Union (EU) are obliged to produce every 5th year noise maps for major roads, major railways and major airports and for larger agglomerations. 
Cohort-specific analysis
The main model fit and assumptions for linear regression were checked using a centrally developed code: collinearity of predictor variables; distribution of residuals; presence of influential observations. These checks were performed in the model without exposure.
The following model specifications were used in the cohort-specific analyses:
• Model 1: crude (only exposure); fixed-effects model.
• Model 2: adjusted for sex, age (centered), age (centered) squared; fixed-effects model. If the random-effects models did not converge, we accounted for clustering by using the robust variance estimator for the cluster (neighborhood), specifying that the standard errors allow for intragroup correlation, relaxing the usual requirement that the observations be independent. In the TwinGene cohort, consisting of twin pairs by about 50%, a random intercept was introduced for twin pair instead (based on the lower AIC).
Sensitivity meta-analysis and meta-regression
To study the effect of the quality of BP measurement on the estimate, we combined studies in groups according to details of the BP measurement procedure and performed the stratified metaanalysis. First, we divided the studies in 3 groups by the number of consequent measurements:
• Group 1: ≥3 BP measurements (HUBRO, SNAC-K, HNR, KORA included);
• Group 2: ≥2 BP measurements (FINRISK, 60-year-olds, EPIC-Umeå, EPIC-MORGEN, EPIC-Prospect, SAPALDIA, REGICOR added to the studies in Group 1);
• Group 3: <2 measurements (SDPP; DCH, EPIC-Oxford added to the studies in Group 2).
Next, we divided studies by participant's position during the BP measurement:
• Group 1: sitting position (FINRISK, SDPP, TwinGene, EPIC-Oxford, HNR, KORA, REGICOR);
• Group 2: supine position (60-year-olds, EPIC-MORGEN, EPIC-Prospect, and DCH).
Studies where BP was not measured in the same position in all participants (EPIC-Umeå, SNAC-K) were excluded.
Finally, we divided studies by the device used for BP measurement:
• Group 1: using an automated oscillometric device (AOD; included HUBRO, 60-year-olds, EPIC-MORGEN, EPIC-Prospect, HNR, SAPALDIA, REGICOR, DCH, EPIC-Oxford);
• Group 2: using a sphygmomanometer (SM; included FINRISK, SDPP, SNAC-K, EPIC-Umea). Two cohorts where both AOD and SM were used (TwinGene, KORA) were excluded. HNR, where for the few participants the missing values with AOD were replaced by measurements with SM, was included in Group 1.
We carried meta-regression with the metareg command in STATA 12.0, using as the following parameters independent predictors:
• time interval between BP measurement and exposure assessment (year of exposure measurement minus a) first and b) last year of BP measurement, entered as continuous variable, or in 5 year categories, and in 10-year categories;
• mean and standard deviation of LUR exposure;
• geographical position: North, Center, South;
• proportion of participants with road traffic noise levels at the residence > 65 dB,
• cohort characteristics: mean and standard deviation of BP, age, BMI, proportion of participants under BP lowering treatment, with prevalent hypertension, current smokers, frequent alcohol drinkers, practicing no sport, unemployed, with low education.
Meta-regression was performed for systolic BP in medicated and non-medicated participants with PM 2.5 and NO 2 as exposures. The significance level was set to p <0.01 to account for the multiple testing. Table S3 . Adjusted association of traffic-related air pollution (5-µg/m³ increase in PM 2.5 , or 10µg/m³ increase in NO 2 ) with systolic blood pressure (with or without BPLM intake, change in mmHg), prevalent hypertension (odds ratio), and use of blood pressure lowering medication (odds ratio) in the study population, based on multi-pollutant models (N=91,574). Figure S1 . Meta-analysis with traffic load at the major road fragments in categories with systolic and diastolic blood pressure. Legend: BP = blood pressure; BPLM = BP lowering medication; change in mmHg with 95% confidence interval is presented. Adjusted for age, sex, body mass index, smoking status, pack-years, passive smoking, alcohol consumption, physical activity, educational level, economic activity, neighborhood SES In the e xtended meta-analysis, DCH and EPIC-Oxford were added (N=15).
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Stratification by number of consecutive BP measurements:
• ≥3 (N=4): HUBRO, SNAC-K, HNR, KORA included, • SM (N=4): FINRISK, SDPP, SNAC-K, EPIC-Umeå a included. a EPIC-Umeå was included only in the analyses with NO 2 and traffic load at major road fragments, because PM 2.5 was not modeled in this cohort. Figure S3 . Cohort-specific and meta-analysis estimates of association of PM 2.5 with systolic blood pressure: main and extended meta-analysis, stratified by medication status. Legend: BP = blood pressure; BPLM = BP lowering medication; change in mmHg with 95% confidence interval is presented. Figure S4 . Association of PM 2.5 with systolic blood pressure: a comparison of adjustment models from crude to main in medicated and non-medicated with blood-pressure lowering medication, and censored regression.
Legend: BP = blood pressure; BPLM = BP lowering medication; RF = risk factors; RE = random effect for neighborhood; nSES = neighborhood socio-economic status; change in mmHg with 95% confidence interval is presented. Figure S5 . Extended adjustment sets and analysis with back-extrapolated exposures with systolic blood pressure in participants not medicated with blood pressure lowering medication. Legend: BP = blood pressure; BPLM = BP lowering medication; change in mmHg with 95% confidence interval is presented.
Main model: adjusted for age, sex, body mass index, smoking status, pack-years, passive smoking, alcohol consumption, physical activity, educational level, economic activity, neighborhood SES (including a random intercept for neighborhood). Cohorts included: FINRISK, HUBRO, 60-year-olds, SDPP, SNAC-K, TwinGene, EPIC-Umeå (only in analyses with NO 2 and traffic load), EPIC-MORGEN, EPIC-Prospect, HNR, KORA, SAPALDIA (Lugano site with PM 2.5 , all 3 sites with NO 2 and traffic load), and REGICOR;
